VERBESSERTES ZELLKULTURMEDIUM

Patent europeic · EP2563904 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2563904
Numer da la dumonda
EP11717240
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-04-2011
Publitgà
06-03-2013
Concedì
21-01-2015
Stritgà
06-09-2023
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
C12N 5/00 (2006.01)
Prioritad
US 327836 P 26.04.2010
Dumonda PCT
PCT/EP2011/056508 25.04.2011
Publicaziun PCT
WO2011/134920 03.11.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 06-09-2023

    Midada

    Published in Swissreg on 06.09.2023

  2. 16-08-2023

    Midada

    Published in Swissreg on 16.08.2023

  3. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  4. 28-12-2022

    Midada

    Published in Swissreg on 28.12.2022

  5. 22-09-2021

    Midada

    Published in Swissreg on 22.09.2021

  6. 21-01-2015

    Concedì

    Published in Swissreg on 21.01.2015

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

LEIST, Christian

4002 Basel

MEISSNER, Petra

4002 Basel

SCHMIDT, Jörg

4002 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.